V. Campese

V. Campese, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up.

R. Bigazzi, S. Bianchi, V. Campese, 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Chapter 18 – Natriuretic Peptides

V. Campese, M. Nadim, 2005 .

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

R. Bigazzi, S. Bianchi, V. Campese, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

ImmunoDip®: An Improved Screening Method for Microalbuminuria

G. Bakris, V. Campese, M. Davidson, 2004, American Journal of Nephrology.

Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks.

V. Campese, Jeanie Park, 2006, Journal of hypertension.

Evolving role of calcium antagonists in the management of hypertension.

V. Campese, M. Epstein, 2004, The Medical clinics of North America.

Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children

V. Campese, E. Ku, 2009, Pediatric Nephrology.

Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up.

R. Bigazzi, S. Bianchi, G. Baldari, 1991, American journal of nephrology.

Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria.

R. Bigazzi, S. Bianchi, G. Baldari, 1995, Journal of human hypertension.

Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.

V. Campese, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal and Cardiovascular Implications

V. Campese, Principal Discussant, 2005 .

Lixivaptan: a novel vasopressin receptor antagonist

V. Campese, E. Ku, Niloofar Nobakht, 2009, Expert opinion on investigational drugs.

Predictors of blood pressure response to spironolactone.

V. Campese, 2016, Journal of hypertension.

Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?

R. Bigazzi, S. Bianchi, V. Campese, 2000, Current opinion in nephrology and hypertension.

Do HMG-CoA reductase inhibitors improve kidney function? The saga continues.

R. Bigazzi, S. Bianchi, V. Campese, 2011, Journal of nephrology.

Plasma catecholamines and vascular reactivity in uremic and dialysis patients.

V. Campese, S. Massry, K. Iseki, 1984, Contributions to nephrology.

Effect of PTH on blood pressure and response to vasoconstrictor agonists.

V. Campese, S. Massry, K. Iseki, 1985, The American journal of physiology.

Evidence for a role of PTH in the reduced pressor response to norepinephrine in chronic renal failure.

V. Campese, S. Massry, K. Iseki, 1985, Kidney international.

Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats.

V. Campese, S. Massry, K. Iseki, 1986, The American journal of physiology.

Parathyroid hormone and the altered vascular response to norepinephrine in uremia.

V. Campese, S. Massry, J. Collins, 1985, American journal of nephrology.

CHAPTER 65 – Hypertension in Chronic Dialysis Patients

V. Campese, L. Mailloux, 2008 .

Microalbuminuria in Essential Hypertension. Significance for the Cardiovascular and Renal Systems

R. Bigazzi, S. Bianchi, V. Campese, 2000 .

Effect of antihypertensive agents on renal function and on sodium-volume status.

V. Campese, 1989, Advances in experimental medicine and biology.

FUNCTION AND ON SODIUM-VOLUME STATUS

V. Campese, 1989 .

Relationship between plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure during postural stress in normal subjects.

V. Campese, S. Massry, V. Dequattro, 1980, The Journal of laboratory and clinical medicine.

Mechanisms of autonomic nervous system dysfunction in uremia

V. Campese, S. Massry, D. Levitan, 1981 .

Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension.

V. Campese, S. Massry, P. Weidmann, 1980, Kidney international.

Sexual Dysfunction in Uremia

V. Campese, Chaplin L. Liu, 1990 .

Sexual dysfunction in uremia. Endocrine and neurological alterations.

V. Campese, C. Liu, 1990, Contributions to nephrology.

Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure.

V. Campese, S. Massry, M. Smogorzewski, 1989, Kidney international.

Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension.

V. Campese, C. Ferrario, M. Chappell, 2002, American journal of hypertension.

Sympatho-adrenal system and the kidney in hypertension.

V. Campese, 1983, American journal of nephrology.

Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.

V. Campese, S. Massry, U. Elkayam, 1984, Journal of the American College of Cardiology.

Alpha1 adrenergic receptors in mesenteric arteries of rats with chronic renal failure

V. Campese, S. Massry, G. Fadda, 1988 .

Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function.

R. Bigazzi, V. Campese, S. Massry, 1991, American journal of hypertension.

Omapatrilat Versus Lisinopril: Efficacy and Neurohormonal Profile in Salt-Sensitive Hypertensive Patients

V. Campese, K. Lasseter, C. Ferrario, 2001, Hypertension.

Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension.

S. Oparil, R. Bigazzi, S. Bianchi, 1996, Hypertension.

Neurogenic factors and hypertension in chronic renal failure.

V. Campese, 1997, Journal of nephrology.

A vitamin-E-fortified diet reduces oxidative stress, sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats.

V. Campese, S. Ye, 2007, Journal of the American Society of Hypertension : JASH.

Impotence in Uremia

V. Campese, S. Massry, D. Goldstein, 1983 .

Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients.

R. Bigazzi, V. Campese, I. Chervu, 1993, Hypertension.

Salt-sensitive hypertension: renal and cardiovascular implications.

V. Campese, 1999, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients.

V. Campese, S. Massry, Z. Gaciong, 1992, American journal of hypertension.

Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension.

R. Bigazzi, S. Bianchi, G. Baldari, 1992, Nephron.

Microalbuminuria in essential hypertension.

R. Bigazzi, S. Bianchi, V. Campese, 1997, Journal of nephrology.

Renal Osteodystrophy and the Status of Aluminum and Other Trace Metals in CAPD Patients: A Panel * Review

V. Campese, D. Oreopoulos, R. Steiner, 1984 .

Interleukin-1β and neurogenic control of blood pressure in normal rats and rats with chronic renal failure

V. Campese, S. Ye, H. Zhong, 2000 .

Interleukin-1 b and neurogenic control of blood pressure in normal rats and rats with chronic renal failure

V. Campese, S. Ye, H. Zhong, 2000 .

Activity Dependent Stimulation of Sympathetic Nerve − Oxidative Stress Mediates Angiotensin II

V. Campese, Ye Shaohua, Zhong Huiquin, 2005 .

Resistant hypertension and obstructive sleep apnea in end-stage renal disease.

V. Campese, Jeanie Park, 2012, Journal of hypertension.

Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker.

R. Bigazzi, S. Bianchi, G. Baldari, 1991, American journal of hypertension.

Association between hyperlipidemia and microalbuminuria in essential hypertension.

R. Bigazzi, S. Bianchi, V. Campese, 1999, Kidney international. Supplement.

Evidence that prostacyclin modulates the vascular actions of calcium in man.

V. Campese, J. Nadler, R. Horton, 1986, The Journal of clinical investigation.

Orthostatic hypotension: idiopathic and uremic.

V. Campese, 1988, Kidney international. Supplement.

Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function.

V. Campese, S. Massry, M. Solimon, 1986, The American journal of cardiology.

Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain

V. Campese, N. Vaziri, B. Jabbari, 2007, Brain Research.

Cardiovascular instability during hemodialysis.

V. Campese, 1988, Kidney international. Supplement.

Diagnosis and evaluation of secondary hypertension.

V. Campese, S. Nosrati, 1999, Clinical cornerstone.

Contrast-induced acute renal failure.

V. Campese, K. Iseki, 1987, Advances in experimental medicine and biology.

Altered norepinephrine turnover in the brown fat of rats with chronic renal failure.

R. Bigazzi, V. Campese, E. Kogosov, 1994, Journal of the American Society of Nephrology : JASN.

A 19-year-old female with fever, acroparesthesia, and progressive deterioration of renal function.

M. Koss, V. Campese, M. El-Shahawy, 1996, American journal of nephrology.

Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.

V. Campese, N. Vaziri, S. Ye, 2007, American journal of physiology. Renal physiology.

Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension.

V. Campese, S. Massry, D. Levitan, 1982, Kidney international.

Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure.

V. Campese, S. Ye, H. Zhong, 2000, American journal of physiology. Heart and circulatory physiology.

Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease

V. Campese, 2015 .

Neurogenic Factors in Hypertensive Patients with Chronic Renal Failure and on Dialysis

V. Campese, 1996 .

Enhanced Glucose Tolerance in Spontaneously Hypertensive Rats: Pancreatic β-Cell Hyperfunction With Normal Insulin Sensitivity

T. Buchanan, V. Campese, J. Youn, 1992, Diabetes.

Minoxidil therapy in refractory hypertension analysis of 155 patients.

V. Campese, S. Massry, P. Weidmann, 1978, Nephron.

The relationship between body phosphate and blood pressure.

V. Campese, S. Massry, K. Iseki, 1984, Advances in experimental medicine and biology.

The Case for Dual Renin-Angiotensin System Inhibition—Reply

V. Campese, Jeanie Park, E. Ku, 2009 .

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

R. Bigazzi, S. Bianchi, V. Campese, 1998, Journal of hypertension.

Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension.

R. Bigazzi, S. Bianchi, G. Baldari, 1993, American journal of hypertension.

Association Between APOL1 Genotype and Risk of Kidney Replacement Therapy Requirement in Patients Without Diabetes: Does Age Matter?

M. Weir, K. Johansen, V. Campese, 2020 .

Abstract 2173: Effect of High-dose Atorvastatin on Changes in Renal Function: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial

M. Hennerici, L. Goldstein, H. Sillesen, 2007 .

Oxidative stress and sympathetic activity in hypertension.

V. Campese, 2010, American journal of hypertension.

Statins and the kidney: friend or foe?

V. Campese, 2015, The lancet. Diabetes & endocrinology.

Is hypertension in chronic renal failure neurogenic in nature?

V. Campese, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Subdiaphragmatic fluid mimicking loculated pericardial effusion on echocardiography.

V. Campese, S. Massry, S. Rahimtoola, 1984, The American journal of cardiology.

Calcium, parathyroid hormone, and blood pressure.

V. Campese, 1989, American journal of hypertension.

Con: Mesoamerican nephropathy: is the problem dehydration or rehydration?

V. Campese, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Mesoamerican nephropathy: a regional epidemic of chronic kidney disease?

V. Campese, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Drugs, Systemic Diseases, and the Kidney

V. Campese, S. Massry, P. Coratelli, 2012, Advances in Experimental Medicine and Biology.

The Challenges of Blood Pressure Control in Dialysis Patients.

V. Campese, Ravi S. Lakdawala, 2015, Recent advances in cardiovascular drug discovery.

Acute renal failure during intermittent rifampicin therapy.

V. Campese, F. Schena, P. Coratelli, 1973, Nephron.

Minoxidil: A Review of its Pharmacological Properties and Therapeutic Use

V. Campese, 1981, Drugs.

Autonomic nervous system dysfunction in patients with acute renal failure.

V. Campese, S. Massry, D. Levitan, 1982, American journal of nephrology.

Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity.

V. Campese, S. Ye, H. Zhong, 2004, American journal of physiology. Heart and circulatory physiology.

Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).

V. Campese, S. Ye, S. Nosrati, 1997, The Journal of clinical investigation.

Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension

V. Campese, F. Karubian, M. Parise, 1991, Hypertension.

Salt sensitivity in hypertension. Renal and cardiovascular implications.

V. Campese, 1994, Hypertension.

Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

J. Coresh, L. Appel, R. Toto, 1997, Journal of the American Society of Nephrology : JASN.

Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.

V. Campese, S. Ye, H. Zhong, 2002, American journal of hypertension.

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.

S. Bianchi, V. Campese, R Bigazzi, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.

S. Bianchi, G. Baldari, V. Campese, 1994, Hypertension.

Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure

V. Campese, M. Gamburd, Shaohua Ye, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Recent Advances in the Role of the Renal Nervous System and Renin in Hypertension

W. Hsueh, V. Campese, 1987 .

Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension

V. Campese, S. Ye, Huiquin Zhong, 2002, Hypertension.

"Zero ischemia" partial nephrectomy: novel laparoscopic and robotic technique.

V. Campese, I. Gill, M. Aron, 2011, European urology.

Pregnancy in patients on chronic ambulatory peritoneal dialysis.

V. Campese, M. Gadallah, F. Karubian, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

THE TIME COURSE OF THERAPEUTIC INTERVENTIONS FOR COVID-19

A. Armstrong, P. Marik, J. Varon, 2020 .

Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial

M. Hennerici, L. Goldstein, H. Sillesen, 2014, Stroke.

Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs

V. Campese, 2014, Clinical and Experimental Nephrology.

Statin use in patients with diabetes and kidney disease: the Japanese experience.

V. Campese, D. Koya, 2013, Journal of atherosclerosis and thrombosis.

Autonomic nervous system dysfunction in uraemia.

V. Campese, 1990, Nephrology, Dialysis and Transplantation.

Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.

M. Koss, V. Campese, E. Kogosov, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Downregulation of Neuronal Nitric Oxide Synthase and Interleukin-1&bgr; Mediates Angiotensin II-Dependent Stimulation of Sympathetic Nerve Activity

V. Campese, S. Ye, Huiquin Zhong, 2002, Hypertension.

Prognosis in acute renal failure accompanied by jaundice.

V. Campese, P. Coratelli, M. Micelli, 1981, Nephron.

acute injury-induced hypertension Responses of proximal tubule sodium transporters to

V. Campese, S. Ye, P. Leong, 2016 .

Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance.

V. Campese, A. McDonough, H. Zhong, 2003, American journal of physiology. Renal physiology.

Responses of proximal tubule sodium transporters to acute injury-induced hypertension.

V. Campese, A. McDonough, S. Ye, 2003, American journal of physiology. Renal physiology.

Autonomic nervous system dysfunction and impotence in uremia.

V. Campese, S. Massry, D. Goldstein, 1982, American journal of nephrology.

Tuberculosis of the spine (Pott's disease) in patients with end-stage renal disease.

V. Campese, M. El-Shahawy, M. Gadallah, 1994, American Journal of Nephrology.

Hemodynamic alterations and urinary albumin excretion in patients with essential hypertension.

V. Campese, F. Karubian, R Bigazzi, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypertension in a renal transplant recipient.

V. Campese, E. Feinstein, P. Chandrasoma, 1984, American journal of nephrology.

Aldosterone in the Pathogenesis of Chronic Kidney Disease and Proteinuria

V. Campese, Yee Lu, E. Ku, 2010, Current hypertension reports.

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

S. Bianchi, V. Campese, Roberto Bigazzi, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion.

V. Campese, M. El-Shahawy, M. Gadallah, 1993, Nephron.

Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations

V. Campese, V. Dequattro, D. Stein, 1979, Journal of clinical pharmacology.

Serum calcium, parathyroid hormone, and blood pressure.

V. Campese, S. Massry, K. Iseki, 1986, American journal of nephrology.

Sodium, Calcium, and Neurogenic Factors in the Pathogenesis of Essential Hypertension

V. Campese, 1989 .

A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications

V. Campese, 2003, Journal of Clinical and Experimental Nephrology.

Exercise pressor reflex in humans with end-stage renal disease.

V. Campese, H. Middlekauff, Jeanie Park, 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

renal disease sympathetic nerve activity in patients with end-stage Differential distribution of muscle and skin

V. Campese, H. Middlekauff, R. Lyles, 2015 .

Abnormal sympathetic reactivity to the cold pressor test in overweight humans.

V. Campese, H. Middlekauff, Jeanie Park, 2012, American journal of hypertension.

Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

V. Campese, H. Middlekauff, Jeanie Park, 2008, Journal of applied physiology.

The kidney in the hypertensive black.

V. Campese, 1996, Ethnicity & health.

HMG-CoA reductase inhibitors and the kidney.

V. Campese, Bassel Hadaya, Josephine Chiu, 2007, Current hypertension reports.

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.

V. Campese, M. Epstein, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF Study.

S. Bianchi, V. Campese, L. Citterio, 2019, Hypertension.

Effect of sodium intake on plasma catecholamines in normal subjects.

V. Campese, S. Massry, P. Weidmann, 1979, The Journal of clinical endocrinology and metabolism.

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.

S. Bianchi, G. Baldari, V. Campese, 1994, Hypertension.

Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.

G. Bakris, K. Johansen, V. Campese, 2017, Journal of the American Society of Nephrology : JASN.

Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.

S. Bianchi, V. Campese, Roberto Bigazzi, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis.

V. Campese, Jeanie Park, 2007, Journal of clinical hypertension.

Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension.

S. Bianchi, V. Campese, R. Nenci, 1997, Journal of nephrology.

Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.

S. Bianchi, V. Campese, V. Batini, 2006, American journal of hypertension.

Electrophysiological and clinical consequences of hyperkalemia.

V. Campese, Vito M Campese, Gbemisola Adenuga, 2016, Kidney international supplements.

Metabolic and Dietary Influences on Sympathetic Nervous System Activity

V. Campese, Jeanie Park, E. Ku, 2011 .

Pharmacokinetics of Atenolol in Patients Treated With Chronic Hemodialysis or Peritoneal Dialysis

W. D. Mason, V. Campese, S. Massry, 1985, Journal of clinical pharmacology.

Mechanisms of autonomic nervous system dysfunction in uremia.

V. Campese, S. Massry, D. Levitan, 1981, Kidney international.

Pathophysiology of resistant hypertension in chronic kidney disease.

V. Campese, 2014, Seminars in nephrology.

Adverse drug responses: An increasing threat to the well-being of older patients: Comment on "Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older".

E. Schneider, V. Campese, 2010, Archives of internal medicine.

A limited renal injury may cause a permanent form of neurogenic hypertension.

M. Koss, V. Campese, S. Ye, 1998, American journal of hypertension.

Neurogenic factors and hypertension in renal disease.

V. Campese, Vito M. Campese, 2000, Kidney international. Supplement.

Neurogenic factors in renal hypertension

V. Campese, E. Król, 2002, Current hypertension reports.

Sympathetic Renal Innervation and Resistant Hypertension

V. Campese, Jeanie Park, E. Ku, 2011, International journal of hypertension.

Review Article Sympathetic Renal Innervation and Resistant Hypertension 1. Hypertension Resistant to Therapy in Patients with Renovascular Disease and with Chronic Kidney Disease 2. Evidence for Activation of the Sympathetic Nervous System (sns) in Renovascular Hypertension and Kidney Disease

V. Campese, Jeanie Park, E. Ku, 2022 .

The kidney and hypertension: over 70 years of research.

V. Campese, Jeanie Park, 2006, Journal of nephrology.

The kidney and the neurogenic control of blood pressure in renal disease.

V. Campese, Vito M. Campese, 1999, Journal of nephrology.

The time to offer treatments for COVID-19

A. Armstrong, P. Marik, J. Varon, 2021, Expert opinion on investigational drugs.

Measurement of Cardiac Output and Blood Volume During Hemodialysis with Fluorescent Dye Dilution Technique

V. Campese, E. Rubinstein, J. Maarek, 2017, Annals of Biomedical Engineering.

Effects of acute and chronic treatment with clonidine.

V. Campese, S. Massry, Vito M. Campese, 1983, Chest.

Hypertension in renal parenchymal disease: why is it so resistant to treatment?

V. Campese, N. Mitra, D. Sandee, 2006, Kidney international.

The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.

P. Marik, J. Varon, V. Campese, 2021, AIDS reviews.

High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure.

V. Campese, S. Ye, P. Mozayeni, 2002, Journal of nephrology.

Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension.

V. Campese, 1988, The American journal of cardiology.

Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity

S. Bianchi, V. Campese, A. Amoroso, 2003, Journal of Human Hypertension.

Hypertension, hyperlipidemia and microalbuminuria.

S. Bianchi, V. Campese, R Bigazzi, 1997, Contributions to nephrology.

Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat.

V. Campese, S. Massry, L. Brunton, 1985, The American journal of physiology.

Renal consequences of salt and hypertension.

V. Campese, F. Karubian, 1991, Seminars in nephrology.

Salt sensitivity in hypertension: implications for the kidney.

V. Campese, F. Karubian, Vito M. Campese, 1991, Journal of the American Society of Nephrology : JASN.

The unresolved epidemic of chronic kidney disease of uncertain origin (CKDu) around the world: A review and new insights.

V. Campese, 2020, Clinical nephrology.

Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.

V. Campese, H. Liou, W. Yang, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bilateral renal cortical necrosis in two patients with Neisseria meningitidis sepsis.

M. Koss, V. Campese, I. Chervu, 1991, American journal of nephrology.

Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF Study.

S. Bianchi, V. Campese, L. Citterio, 2020 .

Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS.

V. Campese, J. King, J. Todd, 1996, American journal of nephrology.

Calcium, parathyroid hormone, and sympathoadrenal system.

V. Campese, 1986, American journal of nephrology.

Why is salt-sensitive hypertension so common in blacks?

V. Campese, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of hypophosphatemia on brain catecholamines content in the rat.

V. Campese, S. Massry, D. Bhaskaran, 1987, Mineral and electrolyte metabolism.

International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.

G. Parati, G. Mancia, G. Grassi, 2013, Journal of the American College of Cardiology.

Functional Abnormalities of the Autonomic Nervous System in Uremic and Dialysis Patients

V. Campese, S. Massry, 1982 .

Reevaluating the Use of Antihypertensive Medications, a First Step Toward Reducing Polypharmacy in Very Old Patients

V. Campese, E. Schneider, 2010, Journal of clinical hypertension.

Selected Abstracts from the 31th International Vicenza Course on Critical Care Nephrology. Vicenza, June 11-14, 2013

Rachel S. Levy-Drummer, Keith C. Norris, Yuedong Wang, 2013, Blood Purification.

Renovascular disease: Is there still a role for revascularization? .

V. Campese, G. Adenuga, 2018, Clinical nephrology.